Clinical Trial Update: Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy

View source ↗

Summary

This clinical trial is evaluating adherence, persistence, and efficacy of Alirocumab 300 mg in Italian patients with hypercholesterolaemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolaemia

Drugs mentioned

• Praluent (alirocumab)

Snippet

Sponsor: Federico II University | Conditions: Hypercholesterolaemia | Status: RECRUITING